A new study reveals that a common blood pressure medication may also offer unexpected benefits for patients with a specific type of heart failure. Researchers found that the drug, typically prescribed to lower blood pressure, could improve survival rates and reduce hospitalizations in individuals with heart failure with preserved ejection fraction. The findings challenge previous assumptions about treatment options for this challenging condition, which affects millions worldwide. Experts are now calling for further investigation into how widely these results could apply to clinical practice.